Serum procalcitonin predicts anastomotic leaks in colorectal surgery

Firdaus Hayati, Zairul Azwan Mohd Azman, Dian Nasriana Nasuruddin, Luqman Mazlan, Andee Dzulkarnaen Zakaria, Ismail Sagap

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Anastomotic leaks in colorectal surgery results in a high morbidity and mortality rate. Serum procalcitonin levels is known as a sensitive and specific marker of sepsis and could be use as a marker for early detection of a leak allowing early intervention. It may help a clinician decide to perform a CT scan even earlier especially when the diagnosis of a leak is uncertain. The aim of this study is to determine whether serum procalcitonin is a good predictor of anastomotic leak in colorectal surgery. Methodology: Between July 2014 until October 2015, 70 patients undergoing colorectal surgery were prospectively analyzed in a single-center tertiary teaching hospital. Demographic and surgical data were obtained. Serum procalcitonin was taken before surgery and at day 3 (72 hours) postoperatively. During the postoperative period, the patients were observed in the ward for features of anastomotic leak and if present, it was managed accordingly. The primary outcome was to prospectively determine an association between serum procalcitonin levels and an anastomotic leak in patients who underwent colorectal surgery with a primary anastomosis. Result: The rate of anastomotic leak was 4.5% (3 patients) with a mortality rate of 4.3% (3 patients). A rise in serum procalcitonin was statistically significant among patients with anastomotic leak. The optimal procalcitonin cut-off level at postoperative day 3 was 5.27 ng/mL, resulting in 100% sensitivity, 85% specificity, 23% positive predictive value and 100% negative predictive value. Nevertheless, none of the variables showed statistical significance with an anastomotic leak. Conclusion: Procalcitonin is a reliable biochemical marker to help diagnose anastomotic leak in colorectal surgery. Our study has shown that a level of 5 times beyond normal is statistically significant and a value of more than 5.27 ng/mL is confirmatory of a leak.

Original languageEnglish
Pages (from-to)1821-1825
Number of pages5
JournalAsian Pacific Journal of Cancer Prevention
Volume18
Issue number7
DOIs
Publication statusPublished - 1 Jul 2017

Fingerprint

Colorectal Surgery
Anastomotic Leak
Calcitonin
Serum
Mortality
Ambulatory Surgical Procedures
Postoperative Period
Tertiary Care Centers
Teaching Hospitals
Sepsis
Biomarkers
Demography
Morbidity
Sensitivity and Specificity

Keywords

  • Colon
  • Leak
  • Procalcitonin
  • Rectum
  • Surgery

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Serum procalcitonin predicts anastomotic leaks in colorectal surgery. / Hayati, Firdaus; Mohd Azman, Zairul Azwan; Nasuruddin, Dian Nasriana; Mazlan, Luqman; Zakaria, Andee Dzulkarnaen; Sagap, Ismail.

In: Asian Pacific Journal of Cancer Prevention, Vol. 18, No. 7, 01.07.2017, p. 1821-1825.

Research output: Contribution to journalArticle

Hayati, Firdaus ; Mohd Azman, Zairul Azwan ; Nasuruddin, Dian Nasriana ; Mazlan, Luqman ; Zakaria, Andee Dzulkarnaen ; Sagap, Ismail. / Serum procalcitonin predicts anastomotic leaks in colorectal surgery. In: Asian Pacific Journal of Cancer Prevention. 2017 ; Vol. 18, No. 7. pp. 1821-1825.
@article{f7df64d1b587444ead5029cf932c809d,
title = "Serum procalcitonin predicts anastomotic leaks in colorectal surgery",
abstract = "Background: Anastomotic leaks in colorectal surgery results in a high morbidity and mortality rate. Serum procalcitonin levels is known as a sensitive and specific marker of sepsis and could be use as a marker for early detection of a leak allowing early intervention. It may help a clinician decide to perform a CT scan even earlier especially when the diagnosis of a leak is uncertain. The aim of this study is to determine whether serum procalcitonin is a good predictor of anastomotic leak in colorectal surgery. Methodology: Between July 2014 until October 2015, 70 patients undergoing colorectal surgery were prospectively analyzed in a single-center tertiary teaching hospital. Demographic and surgical data were obtained. Serum procalcitonin was taken before surgery and at day 3 (72 hours) postoperatively. During the postoperative period, the patients were observed in the ward for features of anastomotic leak and if present, it was managed accordingly. The primary outcome was to prospectively determine an association between serum procalcitonin levels and an anastomotic leak in patients who underwent colorectal surgery with a primary anastomosis. Result: The rate of anastomotic leak was 4.5{\%} (3 patients) with a mortality rate of 4.3{\%} (3 patients). A rise in serum procalcitonin was statistically significant among patients with anastomotic leak. The optimal procalcitonin cut-off level at postoperative day 3 was 5.27 ng/mL, resulting in 100{\%} sensitivity, 85{\%} specificity, 23{\%} positive predictive value and 100{\%} negative predictive value. Nevertheless, none of the variables showed statistical significance with an anastomotic leak. Conclusion: Procalcitonin is a reliable biochemical marker to help diagnose anastomotic leak in colorectal surgery. Our study has shown that a level of 5 times beyond normal is statistically significant and a value of more than 5.27 ng/mL is confirmatory of a leak.",
keywords = "Colon, Leak, Procalcitonin, Rectum, Surgery",
author = "Firdaus Hayati and {Mohd Azman}, {Zairul Azwan} and Nasuruddin, {Dian Nasriana} and Luqman Mazlan and Zakaria, {Andee Dzulkarnaen} and Ismail Sagap",
year = "2017",
month = "7",
day = "1",
doi = "10.22034/APJCP.2017.18.7.1821",
language = "English",
volume = "18",
pages = "1821--1825",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "7",

}

TY - JOUR

T1 - Serum procalcitonin predicts anastomotic leaks in colorectal surgery

AU - Hayati, Firdaus

AU - Mohd Azman, Zairul Azwan

AU - Nasuruddin, Dian Nasriana

AU - Mazlan, Luqman

AU - Zakaria, Andee Dzulkarnaen

AU - Sagap, Ismail

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background: Anastomotic leaks in colorectal surgery results in a high morbidity and mortality rate. Serum procalcitonin levels is known as a sensitive and specific marker of sepsis and could be use as a marker for early detection of a leak allowing early intervention. It may help a clinician decide to perform a CT scan even earlier especially when the diagnosis of a leak is uncertain. The aim of this study is to determine whether serum procalcitonin is a good predictor of anastomotic leak in colorectal surgery. Methodology: Between July 2014 until October 2015, 70 patients undergoing colorectal surgery were prospectively analyzed in a single-center tertiary teaching hospital. Demographic and surgical data were obtained. Serum procalcitonin was taken before surgery and at day 3 (72 hours) postoperatively. During the postoperative period, the patients were observed in the ward for features of anastomotic leak and if present, it was managed accordingly. The primary outcome was to prospectively determine an association between serum procalcitonin levels and an anastomotic leak in patients who underwent colorectal surgery with a primary anastomosis. Result: The rate of anastomotic leak was 4.5% (3 patients) with a mortality rate of 4.3% (3 patients). A rise in serum procalcitonin was statistically significant among patients with anastomotic leak. The optimal procalcitonin cut-off level at postoperative day 3 was 5.27 ng/mL, resulting in 100% sensitivity, 85% specificity, 23% positive predictive value and 100% negative predictive value. Nevertheless, none of the variables showed statistical significance with an anastomotic leak. Conclusion: Procalcitonin is a reliable biochemical marker to help diagnose anastomotic leak in colorectal surgery. Our study has shown that a level of 5 times beyond normal is statistically significant and a value of more than 5.27 ng/mL is confirmatory of a leak.

AB - Background: Anastomotic leaks in colorectal surgery results in a high morbidity and mortality rate. Serum procalcitonin levels is known as a sensitive and specific marker of sepsis and could be use as a marker for early detection of a leak allowing early intervention. It may help a clinician decide to perform a CT scan even earlier especially when the diagnosis of a leak is uncertain. The aim of this study is to determine whether serum procalcitonin is a good predictor of anastomotic leak in colorectal surgery. Methodology: Between July 2014 until October 2015, 70 patients undergoing colorectal surgery were prospectively analyzed in a single-center tertiary teaching hospital. Demographic and surgical data were obtained. Serum procalcitonin was taken before surgery and at day 3 (72 hours) postoperatively. During the postoperative period, the patients were observed in the ward for features of anastomotic leak and if present, it was managed accordingly. The primary outcome was to prospectively determine an association between serum procalcitonin levels and an anastomotic leak in patients who underwent colorectal surgery with a primary anastomosis. Result: The rate of anastomotic leak was 4.5% (3 patients) with a mortality rate of 4.3% (3 patients). A rise in serum procalcitonin was statistically significant among patients with anastomotic leak. The optimal procalcitonin cut-off level at postoperative day 3 was 5.27 ng/mL, resulting in 100% sensitivity, 85% specificity, 23% positive predictive value and 100% negative predictive value. Nevertheless, none of the variables showed statistical significance with an anastomotic leak. Conclusion: Procalcitonin is a reliable biochemical marker to help diagnose anastomotic leak in colorectal surgery. Our study has shown that a level of 5 times beyond normal is statistically significant and a value of more than 5.27 ng/mL is confirmatory of a leak.

KW - Colon

KW - Leak

KW - Procalcitonin

KW - Rectum

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=85026235566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026235566&partnerID=8YFLogxK

U2 - 10.22034/APJCP.2017.18.7.1821

DO - 10.22034/APJCP.2017.18.7.1821

M3 - Article

AN - SCOPUS:85026235566

VL - 18

SP - 1821

EP - 1825

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 7

ER -